Diabetes Research Today is a free monthly online journal that collates and summarizes the latest research about Diabetes, including details on insulin, type i, type ii, diet, treatment, prevention.

Volume 5 (2008), Issue 2 (February)

1. Role of obesity in complicating and confusing the diagnosis and treatment of diabetes in children.
   Pediatrics, 121(2): 361-8. [Abstract] [Full-text]
2. Diabetes alters LDL receptor and PCSK9 expression in rat liver.
   Arch Biochem Biophys, 470(2): 111-5. [Abstract] [Full-text]
3. Type 2 diabetes mellitus and the risk of open-angle glaucoma the Los Angeles Latino Eye Study.
   Ophthalmology, 115(2): 227-232.e1. [Abstract] [Full-text]
4. Amino-terminal pro-B-type natriuretic peptide testing in patients with diabetes mellitus and with systemic hypertension.
   Am J Cardiol, 101(3): 21-4. [Abstract] [Full-text]
5. Muscle wasting in diabetic and in tumor-bearing rats: role of oxidative stress.
   Free Radic Biol Med, 44(4): 584-93. [Abstract] [Full-text]
6. Reviewing myocardial silent ischemia: specific patient subgroups.
   Int J Cardiol, 124(2): 139-48. [Abstract] [Full-text]
7. Dexamethasone-eluting stents for the prevention of in-stent restenosis: evidence for a differential effect in insulin-dependent and non-insulin-dependent diabetic patients.
   Int J Cardiol, 124(2): 166-71. [Abstract] [Full-text]
8. GLP-1 receptor signaling protects pancreatic beta cells in intraportal islet transplant by inhibiting apoptosis.
   Biochem Biophys Res Commun, 367(4): 793-8. [Abstract] [Full-text]
9. Combined insulin B:9-23 self-peptide and polyinosinic-polycytidylic acid accelerate insulitis but inhibit development of diabetes by increasing the proportion of CD4+Foxp3+ regulatory T cells in the islets in non-obese diabetic mice.
   Biochem Biophys Res Commun, 367(4): 719-24. [Abstract] [Full-text]
10. Interaction of single nucleotide polymorphisms in ADRB2, ADRB3, TNF, IL6, IGF1R, LIPC, LEPR, and GHRL with physical activity on the risk of type 2 diabetes mellitus and changes in characteristics of the metabolic syndrome: The Finnish Diabetes Prevention Study.
    Metabolism, 57(3): 428-36. [Abstract] [Full-text]
11. Phenotype of a patient with a de novo mutation in the hepatocyte nuclear factor 1beta/maturity-onset diabetes of the young type 5 gene.
    Metabolism, 57(3): 416-20. [Abstract] [Full-text]
12. Does the new American Diabetes Association definition for impaired fasting glucose improve its ability to predict type 2 diabetes mellitus in Spanish persons? The Asturias Study.
    Metabolism, 57(3): 399-403. [Abstract] [Full-text]
13. Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) study.
    Metabolism, 57(3): 387-92. [Abstract] [Full-text]
14. Differential effect of atorvastatin and fenofibrate on plasma oxidized low-density lipoprotein, inflammation markers, and cell adhesion molecules in patients with type 2 diabetes mellitus.
    Metabolism, 57(3): 380-6. [Abstract] [Full-text]
15. Estimates of hepatic glyceroneogenesis in type 2 diabetes mellitus in humans.
    Metabolism, 57(3): 305-12. [Abstract] [Full-text]
16. Effect of board certification on antihypertensive treatment intensification in patients with diabetes mellitus.
    Circulation, 117(5): 623-8. [Abstract] [Full-text]
17. Risk profile for cardiovascular morbidity and mortality after lung transplantation.
    Nurs Clin North Am, 43(1): 37-53; vi. [Abstract] [Full-text]
18. Potential role of increased matrix metalloproteinase-2 (MMP2) transcription in impaired adipogenesis in type 2 diabetes mellitus.
    Biochem Biophys Res Commun, 367(4): 725-8. [Abstract] [Full-text]
19. A PAI-1 mutant, PAI-1R, slows progression of diabetic nephropathy.
    J Am Soc Nephrol, 19(2): 329-38. [Abstract] [Full-text]
20. Treatment intensification and blood glucose control among hospitalized diabetic patients.
    J Gen Intern Med, 23(2): 184-9. [Abstract] [Full-text]
21. Overexpression of angiotensinogen increases tubular apoptosis in diabetes.
    J Am Soc Nephrol, 19(2): 269-80. [Abstract] [Full-text]
22. The glomerular transcriptome and a predicted protein-protein interaction network.
    J Am Soc Nephrol, 19(2): 260-8. [Abstract] [Full-text]
23. Effect of a multifactorial intervention on mortality in type 2 diabetes.
    N Engl J Med, 358(6): 580-91. [Abstract] [Full-text]
24. Impairment of hippocampal neurogenesis in streptozotocin-treated diabetic rats.
    Acta Neurol Scand, 117(3): 205-10. [Abstract] [Full-text]
25. Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes.
    Curr Med Res Opin, 24(2): 537-50. [Abstract] [Full-text]
26. An audit on diabetes management in Asian patients treated by specialists: the Diabcare-Asia 1998 and 2003 studies.
    Curr Med Res Opin, 24(2): 507-14. [Abstract] [Full-text]
27. Sitagliptin, a DPP-4 inhibitor for the treatment of patients with type 2 diabetes: a review of recent clinical trials.
    Curr Med Res Opin, 24(2): 489-96. [Abstract] [Full-text]
28. Cost effectiveness of duloxetine in the treatment of diabetic peripheral neuropathic pain in the UK.
    Curr Med Res Opin, 24(2): 385-99. [Abstract] [Full-text]
29. Management of type 2 diabetes in the obese patient: current concerns and emerging therapies.
    Curr Med Res Opin, 24(2): 401-17. [Abstract] [Full-text]
30. Safety and efficacy of insulin detemir basal-bolus therapy in type 1 diabetes patients: 14-week data from the European cohort of the PREDICTIVE study.
    Curr Med Res Opin, 24(2): 369-76. [Abstract] [Full-text]
31. Inhibitors of advanced glycation end-products prevent loss of enteric neuronal nitric oxide synthase in diabetic rats.
    Neurogastroenterol Motil, 20(3): 253-61. [Abstract] [Full-text]
32. Update on the treatment of diabetic retinopathy.
    ScientificWorldJournal, 8: 98-120. [Abstract] [Full-text]
33. Meta-analysis: metformin treatment in persons at risk for diabetes mellitus.
    Am J Med, 121(2): 149-157.e2. [Abstract] [Full-text]
34. Automated detection of diabetic retinopathy: results of a screening study.
    Diabetes Technol Ther, 10(2): 142-8. [Abstract] [Full-text]
35. The long-term efficacy of insulin glargine plus oral antidiabetic agents in a 32-month observational study of everyday clinical practice.
    Diabetes Technol Ther, 10(2): 121-7. [Abstract] [Full-text]
36. A glucose meter accuracy and precision comparison: the FreeStyle Flash Versus the Accu-Chek Advantage, Accu-Chek Compact Plus, Ascensia Contour, and the BD Logic.
    Diabetes Technol Ther, 10(2): 102-10. [Abstract] [Full-text]
37. Blood glucose dynamics.
    Diabetes Technol Ther, 10(2): 81-94. [Abstract] [Full-text]
38. Continuous glucose monitoring and diabetes health outcomes: a critical appraisal.
    Diabetes Technol Ther, 10(2): 69-80. [Abstract] [Full-text]
39. Downregulation of diacylglycerol kinase delta contributes to hyperglycemia-induced insulin resistance.
    Cell, 132(3): 375-86. [Abstract] [Full-text]
40. Role of slow delayed rectifier K+-current in QT prolongation in the alloxan-induced diabetic rabbit heart.
    Acta Physiol (Oxf), 192(3): 359-68. [Abstract] [Full-text]
41. Trends in prevalence and outcomes of pregnancy in women with pre-existing type I and type II diabetes.
    BJOG, 115(4): 445-52. [Abstract] [Full-text]
42. The impact of glycaemic control on outcomes in patients with end-stage renal disease and type 2 diabetes.
    Nephrology (Carlton), 13(2): 124-7. [Abstract] [Full-text]
43. Identification and functional analysis of CBLB mutations in type 1 diabetes.
    Biochem Biophys Res Commun, 368(1): 37-42. [Abstract] [Full-text]
44. The effect of losartan on hemoglobin concentration and renal outcome in diabetic nephropathy of type 2 diabetes.
    Kidney Int, 73(5): 630-6. [Abstract] [Full-text]
45. Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials.
    J Am Coll Cardiol, 51(7): 708-15. [Abstract] [Full-text]
46. The relationship between alcohol consumption and glycemic control among patients with diabetes: the Kaiser Permanente Northern California Diabetes Registry.
    J Gen Intern Med, 23(3): 275-82. [Abstract] [Full-text]
47. Diabetic dermopathy: A subtle sign with grave implications.
    J Am Acad Dermatol, 58(3): 447-51. [Abstract] [Full-text]
48. Geographic distribution of childhood diabetes and obesity relative to the supply of pediatric endocrinologists in the United States.
    J Pediatr, 152(3): 331-6. [Abstract] [Full-text]
49. Autosomal dominant polycystic kidney disease is not a risk factor for post-transplant diabetes mellitus. Matched-pair design multicenter study.
    Arch Med Res, 39(3): 312-9. [Abstract] [Full-text]
50. Expression of CD64, CD206, and RAGE in adherent cells of diabetic patients infected with Mycobacterium tuberculosis.
    Arch Med Res, 39(3): 306-11. [Abstract] [Full-text]
51. GAD-IgG-inducing CD4+Foxp3+Treg cells suppressing diabetes are involved in the increasing ratio of CD80+:CD86+ CELLS in NOD mice.
    Arch Med Res, 39(3): 299-305. [Abstract] [Full-text]
52. Research of PDGF-BB gel on the wound healing of diabetic rats and its pharmacodynamics.
    J Surg Res, 145(1): 41-8. [Abstract] [Full-text]
53. Serum and tear levels of nerve growth factor in diabetic retinopathy patients.
    Am J Ophthalmol, 145(3): 432-7. [Abstract] [Full-text]
54. Does this patient with diabetes have osteomyelitis of the lower extremity?
    JAMA, 299(7): 806-13. [Abstract] [Full-text]
55. Two-year clinical outcomes with drug-eluting stents for diabetic patients with de novo coronary lesions: results from a real-world multicenter registry.
    Circulation, 117(7): 923-30. [Abstract] [Full-text]
56. Neonatal formula feeding leads to immunological alterations in an animal model of type 1 diabetes.
    Pediatr Res, 63(3): 303-7. [Abstract] [Full-text]
57. Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes.
    Nat Rev Mol Cell Biol, 9(3): 193-205. [Abstract] [Full-text]
58. Cushing's syndrome in a clinic population with diabetes.
    Intern Med J, 38(3): 178-82. [Abstract] [Full-text]
59. Are diabetic patients at a greater risk to develop a vocal fold palsy during thyroid surgery than nondiabetic patients?
    Surgery, 143(3): 352-8. [Abstract] [Full-text]
60. Primary prevention of type-2 diabetes and heart disease: action research in secondary schools serving an ethnically diverse UK population.
    J Public Health (Oxf), 30(1): 30-7. [Abstract] [Full-text]
61. Modulation of diabetes in NOD mice by GAD65-specific monoclonal antibodies is epitope specific and accompanied by anti-idiotypic antibodies.
    Immunology, 123(4): 547-54. [Abstract] [Full-text]
62. A follow-up study of the occurrence and consequences of HbA1c measurements in an unselected cohort of non-pharmacologically treated patients with Type 2 diabetes.
    Scand J Prim Health Care, 26(1): 57-62. [Abstract] [Full-text]
63. Delivery of multifactorial interventions by nurse and dietitian teams in a community setting to prevent diabetic complications: a quality-improvement report.
    Am J Kidney Dis, 51(3): 425-34. [Abstract] [Full-text]
64. A longitudinal study of risk factors for incident albuminuria in diabetic American Indians: the Strong Heart Study.
    Am J Kidney Dis, 51(3): 415-24. [Abstract] [Full-text]
65. Studies with an orally bioavailable alpha V integrin antagonist in animal models of ocular vasculopathy: retinal neovascularization in mice and retinal vascular permeability in diabetic rats.
    J Pharmacol Exp Ther, 324(3): 894-901. [Abstract] [Full-text]
66. Current smoking and type 2 diabetes among patients in selected Indian Health Service clinics, 1998-2003.
    Am J Public Health, 98(3): 560-5. [Abstract] [Full-text]
67. Pleiotrophic and anti-inflammatory effects of pioglitazone precede the metabolic activity in type 2 diabetic patients with coronary artery disease.
    Atherosclerosis, 197(1): 311-7. [Abstract] [Full-text]
68. Markers of endothelial dysfunction and low-grade inflammation are associated in the offspring of type 2 diabetic subjects.
    Atherosclerosis, 197(1): 271-7. [Abstract] [Full-text]
69. Family history of diabetes and risk of atherosclerotic cardiovascular disease in Korean men and women.
    Atherosclerosis, 197(1): 224-31. [Abstract] [Full-text]
70. Remarkable increase of apolipoprotein B48 level in diabetic patients with end-stage renal disease.
    Atherosclerosis, 197(1): 154-8. [Abstract] [Full-text]
71. Mortality, causes of death and associated risk factors in a cohort of diabetic patients after lower-extremity amputation: a 6.5-year follow-up study in Taiwan.
    Atherosclerosis, 197(1): 111-7. [Abstract] [Full-text]
72. Prediction of the localization of high-risk coronary atherosclerotic plaques on the basis of low endothelial shear stress: an intravascular ultrasound and histopathology natural history study.
    Circulation, 117(8): 993-1002. [Abstract] [Full-text]
73. Use of alternative thresholds defining insulin resistance to predict incident type 2 diabetes mellitus and cardiovascular disease.
    Circulation, 117(8): 1003-9. [Abstract] [Full-text]
74. Metabolic syndrome and its components as predictors of ischemic stroke in type 2 diabetic patients.
    Stroke, 39(3): 1036-8. [Abstract] [Full-text]
75. Predictive clinical features and outcomes of vitrectomy for proliferative diabetic retinopathy.
    Br J Ophthalmol, 92(3): 365-8. [Abstract] [Full-text]
76. Effect of laser spot diameter on the reproducibility of visual field analysis in diabetic patients with upper temporal retinal vein occlusion.
    Ophthalmologica, 222(2): 64-8. [Abstract] [Full-text]
77. Plasma proteome changes in subjects with Type 2 diabetes mellitus with a low or high early insulin response.
    Clin Sci (Lond), 114(7): 499-507. [Abstract] [Full-text]
78. A model for diabetic nephropathy: advantages of the inducible cAMP early repressor transgenic mouse over the streptozotocin-induced diabetic mouse.
    J Cell Physiol, 215(2): 383-91. [Abstract] [Full-text]
79. Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 with susceptibility to type 2 diabetes in a Japanese population.
    Diabetes, 57(3): 791-5. [Abstract] [Full-text]
80. Retinal arteriolar narrowing predicts incidence of diabetes: the Australian Diabetes, Obesity and Lifestyle (AusDiab) Study.
    Diabetes, 57(3): 536-9. [Abstract] [Full-text]
81. Reversal of streptozotocin-induced diabetes in mice by cellular transduction with recombinant pancreatic transcription factor pancreatic duodenal homeobox-1: a novel protein transduction domain-based therapy.
    Diabetes, 57(3): 757-69. [Abstract] [Full-text]
82. In vitro hyperglycemia or a diabetic intrauterine environment reduces neonatal endothelial colony-forming cell numbers and function.
    Diabetes, 57(3): 724-31. [Abstract] [Full-text]
83. Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control.
    Diabetes, 57(3): 714-23. [Abstract] [Full-text]
84. Increased skeletal muscle tumor necrosis factor-alpha and impaired insulin signaling persist in obese women with gestational diabetes mellitus 1 year postpartum.
    Diabetes, 57(3): 606-13. [Abstract] [Full-text]
85. Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling.
    Diabetes, 57(3): 696-705. [Abstract] [Full-text]
86. The effect of cyclooxygenase-2 inhibition on renal hemodynamic function in humans with type 1 diabetes.
    Diabetes, 57(3): 688-95. [Abstract] [Full-text]
87. Genetic variation and association analyses of the nuclear respiratory factor 1 (nRF1) gene in Chinese patients with type 2 diabetes.
    Diabetes, 57(3): 777-82. [Abstract] [Full-text]
88. Analysis of single nucleotide polymorphisms identifies major type 1A diabetes locus telomeric of the major histocompatibility complex.
    Diabetes, 57(3): 770-6. [Abstract] [Full-text]
89. Therapeutic potential of peroxisome proliferators--activated receptor-alpha/gamma dual agonist with alleviation of endoplasmic reticulum stress for the treatment of diabetes.
    Diabetes, 57(3): 737-45. [Abstract] [Full-text]
90. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.
    Diabetes, 57(3): 678-87. [Abstract] [Full-text]
91. Delayed recovery of cognitive function following hypoglycemia in adults with type 1 diabetes: effect of impaired awareness of hypoglycemia.
    Diabetes, 57(3): 732-6. [Abstract] [Full-text]
92. The role of inflammatory cytokines in diabetic nephropathy.
    J Am Soc Nephrol, 19(3): 433-42. [Abstract] [Full-text]
93. A statistical test for the equality of differently adjusted incidence rate ratios.
    Am J Epidemiol, 167(5): 517-22. [Abstract] [Full-text]
94. Oral administration of GW788388, an inhibitor of TGF-beta type I and II receptor kinases, decreases renal fibrosis.
    Kidney Int, 73(6): 705-15. [Abstract] [Full-text]
95. Diabetes and endometrial cancer: an evaluation of the modifying effects of other known risk factors.
    Am J Epidemiol, 167(5): 607-14. [Abstract] [Full-text]
96. High volume-low intensity exercise camp and glycemic control in diabetic children.
    J Paediatr Child Health, 44(3): 122-8. [Abstract] [Full-text]

© 2004-2008 Diabetes Research Today. All Rights Reserved.